StonvexLoading…
StonvexStonvexStonvexCore line items from BRZE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2026 2026-01-31 | Q4 2025 2025-10-31 | Q3 2025 2025-07-31 | Q2 2025 2025-04-30 |
|---|---|---|---|---|
Revenue | $738.18M | $533.01M | $342.17M | $162.06M |
Operating Income | $-144.76M | $-116.52M | $-78.97M | $-40.22M |
Net Income | $-131.29M | $-99.68M | $-63.69M | $-35.79M |
EPS (Diluted) | $-1.22 | $-0.93 | $-0.60 | $-0.34 |
Total Assets | $1.11B | $1.04B | $1.02B | $889.13M |
Total Liabilities | $489.60M | $438.89M | $423.49M | $414.68M |
Cash & Equivalents | $124.34M | $97.81M | $80.98M | $231.50M |
Free Cash Flow OCF − CapEx | $61.85M | $47.30M | $28.27M | $23.93M |
Shares Outstanding | 107.91M | 107.03M | 105.86M | 104.57M |